WELL — WELL Health Technologies Cashflow Statement
0.000.00%
- CA$1.01bn
- CA$1.42bn
- CA$919.69m
- 30
- 62
- 58
- 48
Annual cashflow statement for WELL Health Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.21 | -30.9 | 18.7 | 16.6 | 29.1 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.348 | 26.1 | 8.73 | 9 | -66.2 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.92 | -11.2 | -6.06 | -20.7 | 6.67 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -5.38 | 22.3 | 76.5 | 65.7 | 10.2 |
Capital Expenditures | -1.13 | -2.68 | -6.4 | -8.11 | -16.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -43.1 | -497 | -31.5 | -73.2 | -44 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -44.2 | -500 | -37.9 | -81.3 | -60.2 |
Financing Cash Flow Items | -6.61 | -21.2 | -28.8 | -28.1 | 134 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 121 | 453 | -52.8 | 10.6 | 134 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 71.2 | -25 | -13 | -5.49 | 88.2 |